99455-13-7Relevant articles and documents
IMIDAZOPIPERAZINONE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS
-
Paragraph 0624; 0626, (2019/10/20)
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases.
Reversible frustrated lewis pair addition of n-heterocycles to unsaturated c-c bonds
Dornan, Peter K.,Longobardi, Lauren E.,Stephan, Douglas W.
supporting information, p. 1521 - 1524 (2014/07/08)
N-Heterocycle-tethered olefins and alkynes are cyclized by addition of the N-heterocycle and B(C6F5)3 across the unsaturation. This activation is demonstrated to be reversible at high temperatures. Georg Thieme Verlag Stuttgart New York.
Synthesis and biological evaluation of 2-(arylethynyl)quinoline derivatives as mGluR5 antagonists for the treatment of neuropathic pain
Son, Myung-Hee,Kim, Ji Young,Lim, Eun Jeong,Baek, Du-Jong,Choi, Kihang,Lee, Jae Kyun,Pae, Ae Nim,Min, Sun-Joon,Cho, Yong Seo
supporting information, p. 1472 - 1476 (2013/03/28)
We described here the synthesis and biological evaluation of mGluR5 antagonists containing a quinoline ring structure. Using intracellular calcium mobilization assay (FDSS assay), we identified compound 5n, showing high inhibitory activity against mGluR5. In addition, it was found that compound 5n has excellent stability profile. Finally, this compound exhibited favorable analgesic effects in spinal nerve ligation model of neuropathic pain, which is comparable to gabapentin.